Explore Our Network

Explore MTEC's network of innovators, investors, and research organizations—along with patents and funding opportunities—advancing medical technologies for military and civilian health.

Showing 7 Patents
Induced expression of brain derived neurotrophic factor (BDNF) for treatment of neuromuscular, neurodegenerative, autoimmune, developmental and/or metabolic diseases

22-05-2018 • US-9974755-B2

ALONSO, ROBERT • GEISLER, JOHN GERARD

Mitochon Pharmaceuticals Inc

Induced expression of brain derived neurotrophic factor (BDNF) for treatment of neuromuscular, neurodegenerative, autoimmune, developmental and/or metabolic diseases

19-09-2017 • US-9763896-B2

ALONSO, ROBERT • GEISLER, JOHN GERARD

Mitochon Pharmaceuticals Inc

Induced expression of brain derived neurotrophic factor (BDNF) for treatment of neuromuscular, neurodegenerative, autoimmune, developmental and/or metabolic diseases

08-08-2023 • US-11717497-B2

ALONSO, ROBERT • GEISLER, JOHN GERARD

Mitochon Pharmaceuticals Inc

DNP and DNP prodrug treatment of neuromuscular, neurodegenerative, autoimmune, developmental, traumatic brain injury, concussion, dry eye disease, hearing loss and/or metabolic diseases

09-08-2022 • US-11406642-B2

GEISLER, JOHN GERARD • ALONSO, ROBERT • CROOKS, PETER ANTHONY • PENTHALA, NARSIMHA REDDY • ALBAYATI, ZAINEB

BioVentures LLC • Mitochon Pharmaceuticals Inc

Induced expression of brain derived neurotrophic factor (BDNF) for treatment of neuromuscular, neurodegenerative, autoimmune, developmental and/or metabolic diseases

15-12-2020 • US-10864173-B2

ALONSO, ROBERT • GEISLER, JOHN GERARD

Mitochon Pharmaceuticals Inc

DNP and DNP prodrug treatment of neuromuscular, neurodegenerative, autoimmune, developmental, traumatic brain injury, concussion, dry eye disease, hearing loss and/or metabolic diseases

04-02-2020 • US-10548900-B2

GEISLER, JOHN GERARD • ALONSO, ROBERT • CROOKS, PETER ANTHONY • PENTHALA, NARSIMHA REDDY • ALBAYATI, ZAINEB

BioVentures LLC • Mitochon Pharmaceuticals Inc

Induced expression of brain derived neurotrophic factor (BDNF) for treatment of Neuromuscular, neurodegenerative, autoimmune, developmental and/or metabolic diseases

05-03-2019 • US-10220006-B2

ALONSO, ROBERT • GEISLER, JOHN GERARD

Mitochon Pharmaceuticals Inc

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.